Verbatim response from Claude
Compounded Tirzepatide Availability
This is a nuanced situation that's changed recently:
Current Status
The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which means most compounding pharmacies must stop making it. The FDA has been taking enforcement action against compounders.
What Still May Be Legitimate
- 503B outsourcing facilities may have limited ongoing authorization in some cases
- 503A pharmacies can still compound for individual patients with specific documented needs (allergies to inactive ingredients, specific dosing requirements) with a valid prescription
Somewhat Legitimate Options to Explore
- Hims & Hers - recently adjusted their offerings due to FDA pressure
- LifeMD/Ro - similar situation
- Local compounding pharmacies with a physician's prescription for documented clinical need
Honest Advice
- Be very cautious - many sellers are now operating in gray or illegal territory
- Verify any pharmacy through NABP.pharmacy (National Association of Boards of Pharmacy)
- The branded versions (Zepbound for weight loss, Mounjaro for diabetes) have manufacturer savings programs that can significantly reduce cost
Bottom Line
The window for easy access to compounded tirzepatide has largely closed. Branded options with coupons may now be your most straightforward legitimate path.
Want help finding manufacturer savings programs?